4.7 Article

Hypertension and obesity moderate the relationship between β-amyloid and cognitive decline in midlife

期刊

ALZHEIMERS & DEMENTIA
卷 15, 期 3, 页码 418-428

出版社

WILEY
DOI: 10.1016/j.jalz.2018.09.008

关键词

Preclinical Alzheimer's disease; beta-amyloid; Hypertension; Obesity; Depression; Neuropsychology

资金

  1. National Institutes of Health (NIH) National Center for Advancing Translational Sciences
  2. National Institute of Child Health and Human Development [P30 HD03352]
  3. NIH [R01 AG021155, R01 AG027161, ADRC P50 AG033514, R01AG037639, R01 AG054059, F30 AG054115, T32 GM007507, T32 GM008692, T32 CA009206]
  4. [UL1TR00427]

向作者/读者索取更多资源

Background: This study tested if central obesity, hypertension, or depressive symptoms moderated the relationship between beta-amyloid (A beta) and longitudinal cognitive performance in late middle-aged adults enriched for Alzheimer's disease (AD) risk. Methods: Participants (n = 207; ages = 0-70 years; 73% parental AD) in the Wisconsin Registry for Alzheimer's Prevention study completed 3+ neuropsychological evaluations and a [C-11]PiB positron emission tomography scan or lumbar puncture. Linear mixed-effects regression models tested interactions of risk factor X Ab X visit age on longitudinal Verbal Learning & Memory and Speed & Flexibility factor scores. Results: The relationship between Ab and Verbal Learning & Memory decline was moderated by hypertension (chi(2)((1)) = 3.85, P = .04) and obesity (chi(2)((1)) = 6.12, P = .01); those with both elevated Ab and the risk factor declined at faster rates than those with only elevated Ab or elevated risk factors. Conclusion: In this cohort, hypertension and obesity moderated the relationship between Ab and cognitive decline. Published by Elsevier Inc. on behalf of the Alzheimer's Association.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据